Skip to main content

High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.

Publication ,  Journal Article
Steuber, CP; Fernbach, DJ; Starling, KA; Falletta, JM
Published in: Cancer Chemother Rep
1974

Duke Scholars

Published In

Cancer Chemother Rep

ISSN

0069-0112

Publication Date

1974

Volume

58

Issue

3

Start / End Page

417 / 419

Location

United States

Related Subject Headings

  • Time Factors
  • Leukocyte Count
  • Leukemia, Myeloid
  • Leukemia, Lymphoid
  • Leukemia
  • Humans
  • Cyclophosphamide
  • Clinical Trials as Topic
  • Child, Preschool
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Steuber, C. P., Fernbach, D. J., Starling, K. A., & Falletta, J. M. (1974). High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep, 58(3), 417–419.
Steuber, C. P., D. J. Fernbach, K. A. Starling, and J. M. Falletta. “High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.Cancer Chemother Rep 58, no. 3 (1974): 417–19.
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep. 1974;58(3):417–9.
Steuber, C. P., et al. “High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.Cancer Chemother Rep, vol. 58, no. 3, 1974, pp. 417–19.
Steuber CP, Fernbach DJ, Starling KA, Falletta JM. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. Cancer Chemother Rep. 1974;58(3):417–419.

Published In

Cancer Chemother Rep

ISSN

0069-0112

Publication Date

1974

Volume

58

Issue

3

Start / End Page

417 / 419

Location

United States

Related Subject Headings

  • Time Factors
  • Leukocyte Count
  • Leukemia, Myeloid
  • Leukemia, Lymphoid
  • Leukemia
  • Humans
  • Cyclophosphamide
  • Clinical Trials as Topic
  • Child, Preschool
  • Child